PA5108 Latanoprost FA SR Ocular Implant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PA5108 Latanoprost FA SR Ocular Implant, covering 2025-11-20 to 2025-11-20. Get the full timeline:
Most recent: Clinical Trial Update: Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma [Phase 1]